Phlebotomy Essentials
6th Edition
ISBN: 9781451194524
Author: Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher: JONES+BARTLETT PUBLISHERS, INC.
expand_more
expand_more
format_list_bulleted
Question
47. A detriment of using an EHR system is
a. it increases the documentation process.
b. file and storage expenses are increased
c. transcription costs are increased .
d. disruptions of the Internet may occur.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution
Trending nowThis is a popular solution!
Step by stepSolved in 3 steps
Knowledge Booster
Similar questions
- Out of these associations between a potential exposure (risk factor) and an outcome (health condition or disease), identify the one that is most likely to be causal based on the "strength" of the association. Assume that you no nothing else about the factors and/or the outcomes. Please note: the values of some associations are hypothetical/imaginary, the associations are plausible a. A number of chemicals in tobacco products have been shown to induce cancers in laboratory settings b. Men employed in occupations requiring them to sweep chimneys with tars and/or mineral oils have been shown to have 200 times risk of dying from scrotal cancer compared with men not engaged in such occupations. c. Those who regularly engage in moderate to high intensity physical activity are half as likely to suffer a premature cardiac event compared with those who do not exercise at all. d. Adults who frequently experience inadequate and/or poor quality sleep at night are…arrow_forwardWhat security risks exist within health care information systems? Why do these vulnerabilities still exist? Explain. What can be done to address these vulnerabilities? Who should be most responsible for oversight of these issues?arrow_forward2. What is referred to as "the action phase"? A. Assessment B. Diagnosis C. Planning D. Implementation E. Evaluationarrow_forward
- What are some challenges that you foresee when implementing Precision Medicine (which includes Pharmacogenomics and Immunogenomics as well as Risk Screenings for certain cancers)? This can include ethical, financial, social, legal, etc. challenges. Please provide some examples when discussing your identified challenges. How might you tackle these challenges you comment on above? How might your solutions influence/impact the patient when utilizing Precision Medicine?arrow_forwardWhich of the following statements are true about the Hatch-Waxman Act? Select one or more: a. The Act benefits the manufacturer of reference drugs by extending the patent. O b. The Act benefits the manufacturer of reference drugs by eliminating reporting requirements for changes in the manufacturing process. O c. The Act benefits the manufacturer of generics drugs by eliminating reporting requirements for changes in the manufacturing process. O d. The Act benefits the manufacturer of generics drugs by eliminating the need for clinical trials.arrow_forwardWhich coding is correct for a 4-hour-long infusion of pre-packaged electrolytes and normal saline to a patient in observation status?A.96365, 96366 X 3 B. 96374, 96375 X 3C. 96360, 96361 X 3 D. Observation status patients are paid by MS-DRG, so the CPT would not be coded.arrow_forward
- 1. Which of the following makes it especially difficult for veterinarians to determine if an opioid is truly indicated? A. Opioids used in veterinary medicine are not used in human medicine B. Our patients can’t talk C. Our patients always require larger doses than humans D. All of the above 2. Which of the following is/are potential problems with PDMPs in veterinary medicine? A. Determining how to report the data B. Potential HIPPA violations when reviewing the system seeing the client’s medical information C. How to tie pets to the people that we are trying to monitor D. All of the above 3. Which schedule of controlled substance has no accepted medical use? A. CI B. CII C. CIII D. CIV 4. Which state specific regulatory agencies do you need to be familiar with to know how they regulate controlled substances at the state level? A. Local DEA Field Office B. State Board of Pharmacy C. State Veterinary Board D. All of the…arrow_forwardFive-year-old Carlo is admitted with a diagnosis of nephrosis and an infected wound on his left leg. When Carlo's parents came to visit, the nurse noticed his apparent closeness to his mom. Based on Freud's psychosexual theory of development, preschool Carlo is in which stage of development? genital phallic oral analarrow_forwardA research study is said to be double-blind if A. a change that reflects the participants’ expectations is observed B. the subject knows that he/she is receiving two treatments during the experiment C. neither the subjects nor the investigators know which study group is receiving the placebo D. the placebo has two possible effects on the study grouparrow_forward
- 212. A patient's family does not know the patient's end-of-life care preferences, but assumes that they know what is best for the patient under the circumstances. This assumption reflects:a. justice.b. paternalism.c. pragmatism.d. veracity.arrow_forwardA dose-limiting toxicity is: to A. B. a severe side effect that a patient cannot tolerate without life threatening risks. C. the total dose of a drug given throughout a cycle of treatment. D. a known and expected side effect that is unwanted and unpleasant. the total amount of a specific drug that is safely given over a patient's lifetime.arrow_forwardA physician is treating two different patients. Patient A is being treated with gentamicin (therapeutic index of 3) while patient B is being treated with benzyl penicillin (therapeutic index greater than 100). The initial treatments for both of these patients have failed. Which patient can SAFELY receive a dose increase? A. Patient A B. Patient Barrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
- Phlebotomy EssentialsNursingISBN:9781451194524Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)Publisher:JONES+BARTLETT PUBLISHERS, INC.Gould's Pathophysiology for the Health Profession...NursingISBN:9780323414425Author:Robert J Hubert BSPublisher:SaundersFundamentals Of NursingNursingISBN:9781496362179Author:Taylor, Carol (carol R.), LYNN, Pamela (pamela Barbara), Bartlett, Jennifer L.Publisher:Wolters Kluwer,
- Fundamentals of Nursing, 9eNursingISBN:9780323327404Author:Patricia A. Potter RN MSN PhD FAAN, Anne Griffin Perry RN EdD FAAN, Patricia Stockert RN BSN MS PhD, Amy Hall RN BSN MS PhD CNEPublisher:Elsevier ScienceStudy Guide for Gould's Pathophysiology for the H...NursingISBN:9780323414142Author:Hubert BS, Robert J; VanMeter PhD, Karin C.Publisher:SaundersIssues and Ethics in the Helping Professions (Min...NursingISBN:9781337406291Author:Gerald Corey, Marianne Schneider Corey, Cindy CoreyPublisher:Cengage Learning
Phlebotomy Essentials
Nursing
ISBN:9781451194524
Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:JONES+BARTLETT PUBLISHERS, INC.
Gould's Pathophysiology for the Health Profession...
Nursing
ISBN:9780323414425
Author:Robert J Hubert BS
Publisher:Saunders
Fundamentals Of Nursing
Nursing
ISBN:9781496362179
Author:Taylor, Carol (carol R.), LYNN, Pamela (pamela Barbara), Bartlett, Jennifer L.
Publisher:Wolters Kluwer,
Fundamentals of Nursing, 9e
Nursing
ISBN:9780323327404
Author:Patricia A. Potter RN MSN PhD FAAN, Anne Griffin Perry RN EdD FAAN, Patricia Stockert RN BSN MS PhD, Amy Hall RN BSN MS PhD CNE
Publisher:Elsevier Science
Study Guide for Gould's Pathophysiology for the H...
Nursing
ISBN:9780323414142
Author:Hubert BS, Robert J; VanMeter PhD, Karin C.
Publisher:Saunders
Issues and Ethics in the Helping Professions (Min...
Nursing
ISBN:9781337406291
Author:Gerald Corey, Marianne Schneider Corey, Cindy Corey
Publisher:Cengage Learning